Melanie Whittington

INNOVATION COUNCIL MEMBER
Head, Leerink Center for Pharmacoeconomics, MEDACorp

Melanie (Mel) Whittington is a Managing Director and Head of the Leerink Center for Pharmacoeconomics, where she leads efforts to demonstrate the societal impacts of healthcare treatments and to discuss the importance of incentives for innovation in the US. The Leerink Center for Pharmacoeconomics is a division of MEDACorp which is an affiliate of Leerink Partners. She is also a Senior Fellow within the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center.

Prior to joining MEDACorp, Mel was the Managing Director and Founder of Valusphere, a health economic consultancy that tested novel methods, advised on value demonstration, and provided training to value assessment stakeholders. Previously to Valusphere, she was the Director of Health Economics at the Institute for Clinical and Economic Review and was faculty within the School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. She has a PhD in Health Services Research, an MS in Health Sciences, and a BS in Biological Sciences.